Prevention of fasting-mediated bone marrow atrophy by leptin administration

Cell Immunol. 2012;273(1):52-8. doi: 10.1016/j.cellimm.2011.11.007. Epub 2011 Dec 4.

Abstract

Leptin is an adipokine that regulates body weight. In the current study, we demonstrate that continuous injection of leptin prevents the lymphocyte reduction observed in fasted mice, especially the immature B cell populations in the bone marrow. Although leptin administration reduced apoptotic cells in the bone marrow of fasted mice, it did not prevent glucocorticoid-mediated apoptosis in vitro. Bone marrow atrophy has also been shown in the leptin receptor-deficient db/db mice. In order to investigate the mechanisms underlying these processes, we transplanted bone marrow cells from db/db or control (+m/+m) mice into C.B-17/lcr-scid/scid mice. We found that the spleen and bone marrow B cell populations were completely reconstituted when db/db and +m/+m cells were transplanted into scid mice. Our findings suggest that direct interactions between leptin and bone marrow cells are not essential for the development of B cells in a metabologically normal environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • B-Lymphocytes / cytology
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / metabolism
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / drug effects*
  • Bone Marrow Cells / metabolism
  • Cell Count
  • Fasting / physiology*
  • Female
  • Leptin / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, SCID
  • RNA / chemistry
  • RNA / genetics
  • Receptors, Leptin / deficiency
  • Receptors, Leptin / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Leptin
  • Receptors, Leptin
  • leptin receptor, mouse
  • RNA